Browsing Tag
HER2 breast cancer imaging
1 post
Is Imagion Biosystems (ASX: IBX) on the cusp of a breakout? FDA optimism lifts Phase 2 hopes, but market sentiment remains cautious
Imagion Biosystems is progressing toward a key FDA filing and Phase 2 trial for its HER2 imaging agent. Find out why IBX could be at a turning point.